Transcatheter Closure of perimembranous ventricular septal defects with the Amplatzer asymmetris ventricular septal defect occluder:immediate results and long-term follow-up

王凡,汤宝鹏,马依彤,木胡牙提·乌拉斯汉,穆玉明,杨毅宁
DOI: https://doi.org/10.3969/j.issn.1009-5551.2004.03.015
2004-01-01
Abstract:Objective: To evaluate the long-term therapeutic effect of transcatheter closure of perimembranous ventricular septal defect(PMVSD) using Amplatzer asymmetris ventricular septal defect occluder. Methods: 25 patients with PMVSD were treated by the occluder through the percutaneous procedure under fluoroscopy, angiography and TTE. The mean diameter of the VSDs was 6.56±2.78 mm (ranged from 3 to 15mm). Transthoracic echocardiography (TTE), ECG, and X-ray examination were done 3-day, 3-month, 6-month and 1-year after the procedure to evaluate the efficiency. Results: The success rate of placement of Amplatzer occluder was 100% and no complications occurred during the procedure. Trivial to small residual shunts were found in 2 cases (8%) immediately after the procedure. A 3-month follow-up was completed in 21 patients and no residual shunt was found through TTE. The median left ventricle end-diastolic dimension (LVEDD) had significant decreased from 47.57±8.23 to 45.67 ±8.40 mm (P0.05). One patient had complete heart block witnin 12 hours. X-ray examination showed that both pulmonary vascularity and heart size were improved. Conclusion: Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetris ventricular septal defect occluder is an good method with a high success rate of placement and a good occlusion effect and no significant complications and reliable long-term effect. Further new complications with this device remains to be studied.
What problem does this paper attempt to address?